Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis
Clinical trial NCT06005168 · COMPLETED
Trial details
- NCT number
- NCT06005168
- Sponsor
- University of Michigan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-08
- Primary completion
- 2025-10-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.